Document |
Document Title |
WO/2023/068123A1 |
Silicone-modified pullulan characterized by being an addition reaction product of component (a) and component (b), where (a) is a pullulan having a moisture content of 1.0 mass% or less and a calcium content of less than 100 ppm, and (b)...
|
WO/2023/069870A1 |
Fluid contaminants may be prevalent in many industries, such as the mining industry. Functionalized saccharide polymers comprising two or more monosaccharide units linked by glycosidic bonds and having a portion of the monosaccharide uni...
|
WO/2023/066163A1 |
The present invention relates to the field of food processing. Disclosed are an exopolysaccharide separated from Lactobacillus delbrueckii and Streptococcus thermophilus fermented yoghourt and an application thereof. The neutral exopolys...
|
WO/2023/065439A1 |
The present invention relates to the cross-technical fields of medicine, material chemistry, glycobiology and the like, in particular to a sulfonated hyaluronic acid compound, a preparation method therefor and an application thereof. The...
|
WO/2023/065541A1 |
Disclosed in the present invention are a composite material with a rapid blood coagulation effect and a preparation method therefor, which belong to the technical field of biomedicine. The composite material with the rapid blood coagulat...
|
WO/2023/062129A1 |
The invention pertains to a sugar beet pectin comprising at least 12 wt% protein, based on the total weight of the sugar beet pectin.
|
WO/2023/061065A1 |
The present invention provides a process for extracting pullulan polysaccharide from high-viscosity fermentation broth. The process comprises the following steps: (1) removing thalli from the fermentation broth; (2) removing protein; (3)...
|
WO/2023/060671A1 |
A traditional Chinese medicine polysaccharide feed additive, and a preparation method therefor and the use thereof. The additive consists of the following components in parts by weight: 5-10 parts of lactoferrin, 3-5 parts of medium-chai...
|
WO/2023/062185A1 |
The invention provides a method of preparing a biocompatible hydrogel, a hydrogel obtainable by said method, a biocompatible hydrogel for non-covalent immobilization of one or more enzyme(s), and a composition comprising any of said hydr...
|
WO/2023/059499A1 |
The present invention includes a method for the preparation of chitin nanocrystals, nanowhiskers, or both directly from a raw chitinous biomass without the prior isolation of a raw chitin polymer using an ionic liquid comprising: drying ...
|
WO/2023/056996A1 |
The present invention refers to a method and device for the preparation of microfibres and nanofibres based on hyaluronic acid and/or a water-soluble metal or non-metal salt thereof or a mixture of salts and/or a derivative of hyaluronic...
|
WO/2023/057712A1 |
The present invention relates to the field of compositions comprising a polymer bearing a chelating group capable of chelating one or more metals, and to the various uses thereof. In particular, the present invention relates to compositi...
|
WO/2023/055307A1 |
A method for extracting Hevea Latex Polysaccharides (HLPs) from process effluent in the rubber manufacturing industry. The effluent obtained from the squeeze-milling of rubber coagula is optionally filtered in order to remove debris and ...
|
WO/2023/048126A1 |
The present invention addresses the problem of providing, for example: an EPS manufacturing method in which EPS productivity is improved; EPS which is manufactured using the manufacturing method; a manufacturing method for fermented prod...
|
WO/2023/049727A1 |
The invention relates to substituted cyclodextrin (CD) compounds having C9 to C25 optionally substituted alkyl-based linker groups, which irreversibly inhibit viruses and are useful in the treatment of viral infections. While the compoun...
|
WO/2023/047790A1 |
One purpose of the present invention is to provide a production method of a cyclic oligosaccharide by which a cyclic oligosaccharide can be efficiently synthesized. Another purpose of the present invention is to provide a novel cyclic ol...
|
WO/2023/049167A1 |
The present disclosure provides a process for preparing glycated chitosan and compositions comprising glycated chitosan.
|
WO/2023/041836A1 |
The present invention relates to a hydrogel precursor composition and to a bioink obtainable from the hydrogel precursor composition, as well as a method of preparing and using the same. More specifically, the invention relates to a bioi...
|
WO/2023/040033A1 |
The present invention relates to the technical field of preparation of food and cosmetic raw materials. Disclosed are an anti-oxidant repair Ganoderma lucidum extract and a preparation method therefor. The preparation method comprises: m...
|
WO/2023/039024A1 |
A method for isolating lignin and synthesizing nanocellulose from lignocellulosic materials is provided. The method describes crushing and grinding the lignocellulosic material under pressure with a solid acid catalyst to induce a solid-...
|
WO/2023/036203A1 |
A Cs-4 fermented mycelium heteropolysaccharide, a preparation method therefor and a use thereof. The polysaccharide structure is shown below, where N is selected from 6-104. The polysaccharide can be used for preventing or treating chron...
|
WO/2023/036219A1 |
Provided in the present invention are a homogalacturonan, a complex, and a preparation method therefor and the use thereof. Provided in the present invention is a preparation method for homogalacturonan, comprising the following steps: s...
|
WO/2023/034881A1 |
The present disclosure relates to mRNA, self-replicating RNA, and temperature-sensitive, self-replicating RNA encoding a cancer antigen. The RNA constructs are suitable for cancer immunotherapy in a mammalian subject, such as a human sub...
|
WO/2023/033276A1 |
The present invention relates to a pharmaceutical composition comprising a gamma-cyclodextrin-based polymer for prevention or treatment of cholesterol metabolism-related disease, and a use thereof. A pharmaceutical composition comprising...
|
WO/2023/027330A1 |
The present invention relates to a hyaluronic acid (HA) filler composition using polyethylene glycol (PEG) and glycolic acid (GA) as crosslinking agents and a method for preparing same. The present invention is characterized by preparati...
|
WO/2023/025943A1 |
A diblock polymer comprising a first component covalently bound via a linker to a second component; wherein said first component is an oligomer comprising at least 50 mol% L-guluronic acid residues and having a degree of polymerisation n...
|
WO/2023/026010A1 |
The invention relates to a method for preparing a mixture of poorly-digestible alpha-glucans from a substrate rich in oligosaccharides having a degree of polymerisation (DP) of 4.
|
WO/2023/022554A1 |
The present invention provides a method for preparing a swellable polymer to which an object is fixed. The preparation method of the present invention comprises a step of absorbing a solution of an object, which is dissolved or dispersed...
|
WO/2023/023648A1 |
Compositions and methods are disclosed for enhancing the bioavailability and/or increasing the stability of at least one agent by modifying the at least one agent with cyclodextrin. Pharmaceutical compositions including the cyclodextrin-...
|
WO/2023/019987A1 |
The present invention belongs to the field of food processing, and discloses a neutral exopolysaccharide of lactobacillus plantarum and the use thereof. The neutral exopolysaccharide of lactobacillus plantarum of the present invention is...
|
WO/2019/080950A9 |
The invention relates to a solvent-free polymer electrolyte for use in a rechargeable lithium-ion secondary battery, comprising a polymer matrix which is conductive for lithium-ions and a lithium salt. The polymer matrix has at least one...
|
WO/2023/012115A1 |
The present invention relates to an active ingredient comprising oligo-glucans, obtained from the cytosolic fraction of a yeast of the species Saccharomyces cerevisiae, a cosmetic composition containing same and cosmetic uses thereof, in...
|
WO/2023/013426A1 |
[Problem] To provide: a crosslinked EPDM composition which enables the re-dissolution of a polyrotaxane having a hydrosilyl group in a primary solvent after solidification and therefore enables the handling of the polyrotaxane in a solid...
|
WO/2023/011639A1 |
Provided in the present invention are a class of new oligosaccharide linkers and a linking method. By taking a conserved glycosylation site on an antibody as a coupling site, a biantennary oligosaccharide as a linker structure, and struc...
|
WO/2023/012333A2 |
The present invention is directed to gels, cryogels and other polymer scaffolds, solid surfaces, aggregates, films and coatings comprising a soluble chemically modified cross-linked chitosan useful for 3D cell and organoid bioprinting an...
|
WO/2023/006108A1 |
The present invention provides a preparation method for sodium hyaluronate having full molecular weight distribution, the method comprising: step 1): spraying hydrogen peroxide and performing ultraviolet irradiation on a sodium hyalurona...
|
WO/2023/004456A1 |
Described herein is an isolated biological polysaccharide compound. The biological polysaccharide compound may be characterised by being isolated and having: glycosyl linkages comprising 1:3 linked glucopyranosyl residue of 65-95%wt and ...
|
WO/2023/001913A1 |
The present invention relates to chitosan oligomers obtainable by enzymatic hydrolysis of chitosan polymers, compositions containing them, and uses thereof.
|
WO/2023/002959A1 |
Provided are: a chitosan derivative which has an excellent emulsification ability and a high salt-forming rate, and from which it is possible to prepare an emulsification composition such as a highly stable milky lotion by finely dispers...
|
WO/2023/285663A1 |
The present invention provides a hydroxypropyltrialkylammonium hyaluronate and/or salt thereof, having a degree of cationization of more than 1.4.
|
WO/2023/287366A1 |
This invention relates to a method for preparing hyaluronic acid grafted poly(N-isopropylacrylamide) (HA-g-pNIPAM) comprising the steps of: a) preparing a mixture comprising hyaluronic compound, poly(N-isopropylacrylamide) and carbodiimi...
|
WO/2023/287684A1 |
Compositions are disclosed herein comprising an ester derivative of a glucan, wherein the glucan has a degree of substitution (DoS) up to about 3.0 with at least one cationic organic group that is ester-linked to the glucan. Methods are ...
|
WO/2023/287348A1 |
A method for the manufacture of agar or agarose beads, the method comprising the steps of: i) providing a water phase comprising an aqueous solution of agar or agarose at a temperature above the gelling temperature of said aqueous soluti...
|
WO/2023/280235A1 |
The present invention relates to a heparin molecule containing an AT binding sequence and a continuous 2-O-glucuronic acid residue, and a preparation method therefor and the use thereof. The heparin molecule contains an AT binding sequen...
|
WO/2023/282413A1 |
The present invention relates to a homogeneous spherical hyaluronic acid bead gel having a swelling degree of 4,500%-10,000%, which is prepared through a mixed crosslinking reaction step, a second step of crosslinking reaction of a dispe...
|
WO/2023/280084A1 |
The present invention relates to the field of anticoagulant and antithrombotic drugs, and in particular to an application of sulfate gluco-galacto-oligosaccharide in preparation of an anticoagulant and/or antithrombotic drug. Disclosed i...
|
WO/2023/281262A1 |
The invention provides a method for obtaining alginate from macroalgae, in particular from brown seaweed such as Laminaria hyperborea. It further relates to alginate obtained by such a method. More particularly, the invention provides a ...
|
WO/2023/283532A1 |
The present disclosure provides for a method of purifying rubber from a plant that naturally produces rubber, the method including: a) contacting plant material with hot water or a dilute basic aqueous solution, thereby forming a plant m...
|
WO/2023/274748A1 |
A biomedical device is disclosed. The biomedical device includes a polymerization product of a biomedical device-forming mixture containing (a) one or more grafted glycosaminoglycan polymers including a glycosaminoglycan having a polymer...
|
WO/2023/278631A1 |
Provided herein are methods of producing heparin and heparan sulfate from modified cells, such as modified MST cells, and compositions comprising heparin and heparan sulfate isolated from modified cells.
|